Information on IMD32A

Basic details

Name: Immunodeficiency 32A (CD11C-positive/CD1C-positive dendritic cell deficiency) | Acronym: IMD32A
Alt. names:

Gene: IRF8 | MOI: Autosomal dominant | Mechanism of action:

No. of cases in DB: 0 | First reported in: 2011

Last updated on: 2023-02-28 16:41:18 by

OMIM: 614893

Orphanet: -

MONDO: -

DOID: -

ClinGen:

Description

Individuals with Immunodeficiency 32A (CD11C-positive/CD1C-positive dendritic cell deficiency) have been described as demonstrating disseminated BCG disease that was amenable to treatment, and preventive measures, as well as prompt treatment of infection, may be beneficial; Individuals with Immunodeficiency 32B (monocyte and dendritic cell deficiency) demonstrate immunodeficiency, with severe opportunistic infections, and prophylactic measures and prompt and aggressive treatment of infections may be beneficial; HSCT has been described. Refs. PMIDs: 21524210

Management

Description of management option has not been reviewed yet.

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

0 reported cases added to GenIA

SubjectID Sex Fam.ID AD AFM Validity Country Population Reference & Pub.code

AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).

Summary of clinical findings

[Considering only Definitive and Possible cases]

Rank Clinical term Present Absent Unreported
1 BCGitisarrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
2 Childhood onsetarrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
3 Granulomaarrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
4 Lymphadenopathyarrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
5 Feverarrow icon 1 (50.0%) 0 (0.0%) 1 (50.0%)
6 Lymphadenitisarrow icon 1 (50.0%) 0 (0.0%) 1 (50.0%)

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

Summary of treatment outcomes

[Considering only Definitive and Possible cases]

Treatment ⓘ Responses & clinical indications

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.